For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
LPI (LP Information)' newest research report, the "Antibody Production Industry Forecast" looks at past sales and reviews total world Antibody Production sales in 2022, providing a comprehensive analysis by region and market sector of projected Antibody Production sales for 2023 through 2029. With Antibody Production sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibody Production industry.
This Insight Report provides a comprehensive analysis of the global Antibody Production landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antibody Production portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Antibody Production market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibody Production and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibody Production.
The global Antibody Production market size is projected to grow from US$ 8655.4 million in 2022 to US$ 14140 million in 2029; it is expected to grow at a CAGR of 14140 from 2023 to 2029.
United States market for Antibody Production is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Antibody Production is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Antibody Production is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Antibody Production players cover Thermo Fisher Scientific, Inc., GE Healthcare, Sartorius AG, Merck KGaA, Eppendorf AG, Cellab GmbH, Pall Corp., INTEGRA Biosciences AG and FiberCell Systems Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody Production market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Polyclonal antibody
- Monoclonal antibody
- Murine
- Chimeric
- Humanized
Segmentation by application
- Pharmaceutical and biotechnology companies
- Research laboratories
- Others
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Thermo Fisher Scientific, Inc.
- GE Healthcare
- Sartorius AG
- Merck KGaA
- Eppendorf AG
- Cellab GmbH
- Pall Corp.
- INTEGRA Biosciences AG
- FiberCell Systems Inc.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Antibody Production market?
What factors are driving Antibody Production market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antibody Production market opportunities vary by end market size?
How does Antibody Production break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?